Triumph Capital Management’s Clover Health Investments CLOV Stock Holding History

Triumph Capital Management’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$17.2K	Hold	4,000	–	–	﹤0.01%	1020
2026 Q2	$21K	Sell	4,000 -8	-0.2%	-$27	﹤0.01%	925
2026 Q1	$7.05K	Hold	4,008	–	–	﹤0.01%	1213
2025 Q4	$9.42K	Buy	+4,008	New	+$11K	﹤0.01%	1096
2025 Q2	–	Sell	-11,924	Closed	-$42.8K	–	290
2025 Q1	$42.8K	Sell	11,924 -2,294	-16%	-$9.21K	0.01%	274
2024 Q4	$44.8K	Buy	+14,218	New	+$50.8K	0.02%	272

Other funds holding CLOV

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

IMC Chicago Chicago, Illinois $483B AUM 41.26% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Kestra Private Wealth Services Austin, Texas $9.37B AUM 22.72% 1-Year Est. Return

Triumph Capital Management's CLOV Position: Q3 2026 in Review

Triumph Capital Management held its Clover Health Investments (CLOV) position steady in Q3 2026 at 4,000 shares worth $17.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1020.

Triumph Capital Management first reported a position in CLOV in Q4 2024 and has held it in 6 quarters since. The position peaked at $44.8K in Q4 2024. 104 funds tracked by Wall St. Rank hold CLOV as of Q3 2026.

Triumph Capital Management held 4,000 shares of Clover Health Investments worth $17.2K as of Q3 2026.
Triumph Capital Management left its Clover Health Investments share count unchanged in Q3 2026.
Clover Health Investments made up ﹤0.01% of Triumph Capital Management's portfolio in Q3 2026, its #1020 holding.
Triumph Capital Management first reported a position in Clover Health Investments in Q4 2024 and has held it in 6 quarters since.
Triumph Capital Management's Clover Health Investments position peaked at $44.8K in Q4 2024.
104 funds tracked by Wall St. Rank held Clover Health Investments as of Q3 2026.

Based on Triumph Capital Management's 13F filing for Q3 2026, filed 14 Oct 2026.